[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ironwood Pharmaceuti (IRWD)

Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 712,184
  • Shares Outstanding, K 165,240
  • Annual Sales, $ 296,150 K
  • Annual Income, $ 24,020 K
  • EBIT $ 234 M
  • EBITDA $ 236 M
  • 60-Month Beta 0.20
  • Price/Sales 2.28
  • Price/Cash Flow 15.85
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 90.99% (-31.20%)
  • Historical Volatility 71.62%
  • IV Percentile 8%
  • IV Rank 3.39%
  • IV High 424.87% on 09/17/25
  • IV Low 79.29% on 07/20/26
  • Expected Move (DTE 5) 0.38 (8.87%)
  • Put/Call Vol Ratio 0.16
  • Today's Volume 67
  • Volume Avg (30-Day) 399
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 16,960
  • Open Int (30-Day) 16,086
  • Expected Range 3.93 to 4.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.30
  • Number of Estimates 1
  • High Estimate $0.30
  • Low Estimate $0.30
  • Prior Year $0.24
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.55 +21.41%
on 07/30/26
4.59 -6.10%
on 08/03/26
+0.33 (+8.29%)
since 07/14/26
3-Month
3.14 +37.04%
on 06/09/26
4.88 -11.59%
on 07/08/26
+0.64 (+17.44%)
since 05/14/26
52-Week
1.01 +326.73%
on 09/04/25
5.78 -25.43%
on 01/02/26
+3.24 (+302.80%)
since 08/14/25

Most Recent Stories

More News
Ironwood: Q2 Earnings Snapshot

Ironwood: Q2 Earnings Snapshot

IRWD : 4.31 (+5.64%)
Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results

– Raises full-year 2026 LINZESS ® (linaclotide) U.S. net sales guidance to $1.15 - $1.20 billion, representing greater than 30% increase year-over-year;...

IRWD : 4.31 (+5.64%)
Ironwood Pharmaceuticals Has Been Profitable for Three Quarters Now If That Holds

Barchart Research What to Expect from IRWD Earnings IRWD Generated August 5, 2026 Current Price $4.15 EPS Estimate $$0.26 Consensus Rating Moderate Buy Average Move 13.35% Ironwood Pharmaceuticals Has...

IRWD : 4.31 (+5.64%)
Ironwood Pharmaceuticals to Host Second Quarter 2026 Investor Update Call

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced it will host its second quarter 2026 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 6,...

IRWD : 4.31 (+5.64%)
Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development; STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients

– Ironwood Chief Medical Officer and Head of Research and Drug Development Dr. Michael Shetzline to Retire After 30-Year Career Advancing GI Science and Patient Care ...

IRWD : 4.31 (+5.64%)
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 4 th ...

IRWD : 4.31 (+5.64%)
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)

– Expanded indication extends availability to children ages 2-5 with FC; previously approved in pediatric patients 6 years of age and older – – LINZESS...

IRWD : 4.31 (+5.64%)
Ironwood Pharmaceuticals Q1 Earnings Call Highlights

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported a strong start to 2026 and reiterated its full-year outlook, pointing to sharp first-quarter growth for LINZESS and continued progress toward a confirmatory...

IRWD : 4.31 (+5.64%)
Ironwood: Q1 Earnings Snapshot

Ironwood: Q1 Earnings Snapshot

IRWD : 4.31 (+5.64%)
Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance

– LINZESS® (linaclotide) U.S. net sales of $273 million in Q1 2026, primarily driven by improved net price and 5% EUTRx demand growth year-over-year – – Total revenue...

IRWD : 4.31 (+5.64%)

Business Summary

Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of treatments primarily addressing gastrointestinal diseases. Linzess was launched in collaboration with Allergan for patients suffering from irritable bowel syndrome (IBS-C; 290 mcg) with constipation or chronic idiopathic...

See More

Key Turning Points

3rd Resistance Point 4.84
2nd Resistance Point 4.60
1st Resistance Point 4.45
Last Price 4.31
1st Support Level 4.06
2nd Support Level 3.82
3rd Support Level 3.67

See More

52-Week High 5.78
Last Price 4.31
Fibonacci 61.8% 3.96
Fibonacci 50% 3.39
Fibonacci 38.2% 2.83
52-Week Low 1.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.